cadmium oxide has been researched along with Airflow Obstruction, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Di Cristo, L; Gun'ko, YK; Hutchinson, D; Kickham, L; McCarthy, JE; Movia, D; Müller, J; Prina-Mello, A; Verma, NK; Volkov, Y | 1 |
| Burge, PS; Naidoo, P; Robertson, AS; Thompson, RD; Trotter, SE; Walters, GI | 1 |
2 other study(ies) available for cadmium oxide and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Cadmium nanoparticles citrullinate cytokeratins within lung epithelial cells: cadmium as a potential cause of citrullination in chronic obstructive pulmonary disease.
Topics: A549 Cells; Cadmium Chloride; Cadmium Compounds; Citrullination; Citrulline; Epithelial Cells; Humans; Keratins; Lung; Metal Nanoparticles; Oxides; Protein Processing, Post-Translational; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Smoking | 2018 |
Occupational COPD and emphysema: two case histories.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Cadmium Compounds; Forced Expiratory Volume; Humans; Inhalation Exposure; Lung Transplantation; Male; Metallurgy; Middle Aged; Muscarinic Antagonists; Occupational Diseases; Oxides; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Siblings; Tomography, X-Ray Computed; Vital Capacity | 2019 |